Biden Team to Buy 10 Million Courses of Pfizer Covid Pill (1)

Nov. 16, 2021, 7:10 PM UTC

The Biden administration plans to buy enough of Pfizer Inc.’s new Covid-19 pill to treat 10 million patients, people familiar with the matter say.

Pfizer’s pill to treat the disease caused by the coronavirus showed extraordinary results in a clinical trial, reducing hospitalization and death by 89% among high-risk Covid-19 patients. The company said Tuesday it asked the U.S. Food and Drug Administration for emergency-use authorization for the pill, administered twice a day for five days.

The administration has also ordered about 3.1 million courses of a pill from Merck & Co., and has an option in its ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.